… were tested against COVID-19 in clinical trials… COVID-19 patients. Additionally, administration
of convalescent plasma obtained from recovered COVID-19 patients to infected COVID-19 …

… coronavirus now known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)
… As of February 27, 2020, more than 82 000 cases of coronavirus disease 2019 (COVID-19) (…

… against COVID-19 can be administered in association with influenza vaccination without
particular complications. New drugs against COVID-19, … Finally, the long COVID or Post-COVID …

… Coronavirus disease (COVID-19) presents a broad spectrum … inter-individual variability of
COVID-19 susceptibility and/or … have been associated with COVID-19 susceptibility; while HLA-…

… COVID-19 in suspected individuals and isolation are among the crucial intervention norms in
health management strategies to control the COVID-19 … epidemiology of COVID-19 and the …

… (4) Also, more autopsies of not only the lungs but brains need to be performed in order to
gain deeper insights into the neurotrajectory of COVID-19 infection. In this hour of great distress…

… The rapidly evolving coronavirus disease 2019 (COVID-19) pandemic is placing an
overwhelming burden on health systems and authorities to respond with effective and appropriate …

… Coronavirus disease 2019 (COVID-19) is a newly emerged infectious disease caused by
the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that was declared a …

… Coronavirus disease-19 (COVID-19) is caused by the severe acute respiratory syndrome
coronavirus 2 (… Several diagnostic techniques have been developed to detect COVID-19 in this …

… SARS-CoV-2 is a novel strain of coronavirus that has not been previously identified in … to
be effective for the treatment of COVID-19. Personal protective measures should be followed to …